Lactate and glucose metabolism in severe sepsis and cardiogenic shock.

Surgical Intensive Care Unit, University Hospital, Lausanne, Switzerland.
Critical Care Medicine (Impact Factor: 6.15). 10/2005; 33(10):2235-40. DOI: 10.1097/01.CCM.0000181525.99295.8F
Source: PubMed

ABSTRACT To evaluate the relative importance of increased lactate production as opposed to decreased utilization in hyperlactatemic patients, as well as their relation to glucose metabolism.
Prospective observational study.
Surgical intensive care unit of a university hospital.
Seven patients with severe sepsis or septic shock, seven patients with cardiogenic shock, and seven healthy volunteers.
C-labeled sodium lactate was infused at 10 micromol/kg/min and then at 20 micromol/kg/min over 120 mins each. H-labeled glucose was infused throughout.
Baseline arterial lactate was higher in septic (3.2 +/- 2.6) and cardiogenic shock patients (2.8 +/- 0.4) than in healthy volunteers (0.9 +/- 0.20 mmol/L, p < .05). Lactate clearance, computed using pharmacokinetic calculations, was similar in septic, cardiogenic shock, and controls, respectively: 10.8 +/- 5.4, 9.6 +/- 2.1, and 12.0 +/- 2.6 mL/kg/min. Endogenous lactate production was determined as the initial lactate concentration multiplied by lactate clearance. It was markedly enhanced in the patients (septic 26.2 +/- 10.5; cardiogenic shock 26.6 +/- 5.1) compared with controls (11.2 +/- 2.7 micromol/kg/min, p < .01). C-lactate oxidation (septic 54 +/- 25; cardiogenic shock 43 +/- 16; controls 65 +/- 15% of a lactate load of 10 micromol/kg/min) and transformation of C-lactate into C-glucose were not different (respectively, 15 +/- 15, 9 +/- 18, and 10 +/- 7%). Endogenous glucose production was markedly increased in the patients (septic 14.8 +/- 1.8; cardiogenic shock 15.0 +/- 1.5) compared with controls (7.2 +/- 1.1 micromol/kg/min, p < .01) and was not influenced by lactate infusion.
In patients suffering from septic or cardiogenic shock, hyperlactatemia was mainly related to increased production, whereas lactate clearance was similar to healthy subjects. Increased lactate production was concomitant to hyperglycemia and increased glucose turnover, suggesting that the latter substantially influences lactate metabolism during critical illness.


Available from: Mette M Berger, Jun 03, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although the prognostic value of persistent hyperlactatemia in septic shock is unequivocal, its physiological determinants are controversial. Particularly, the role of impaired hepatic clearance has been underestimated and considered relevant only in patients with liver ischemia or cirrhosis. Our objectives were to establish if endotoxemia impairs whole body net lactate clearance, and to explore a potential role for total liver hypoperfusion during the early phase of septic shock. After anesthesia twelve sheep were subjected to a hemodynamic/perfusion monitoring including hepatic and portal catheterization, and a hepatic ultrasound flow probe. After stabilization (point A), sheep were alternatively assigned to LPS (5 mcg/kg bolus followed by 4 mcg/kg/h) or sham for a 3 h study period. After 60 min of shock, animals were fluid resuscitated to normalize MAP. Repeated series of measurements were performed immediately after fluid resuscitation (point B), and one (point C) and two hours later (point D). Monitoring included systemic and regional hemodynamics, blood gases and lactate measurements, and ex-vivo hepatic mitochondrial respiration at point D. Parallel exogenous lactate and sorbitol clearances were performed at points B and D. In both cases the procedure included an IV bolus followed by serial blood sampling to draw a curve using the least squares method. A significant hyperlactatemia was already present in LPS as compared to sham animals at point B (4.7 [3.1-6.7] vs. 1.8 [1.5-3.7] mmol/L) increasing to 10.2 [7.8-12.3] mmol/L at point D. A significant increase in portal and hepatic lactate levels in LPS animals was also observed. However, no difference in hepatic DO2, VO2 or O2 extraction, total hepatic blood flow (915 [773-1046] vs. 655 [593-1175] ml/min at point D), mitochondrial respiration, liver enzymes or sorbitol clearance within groups was found. However, there was a highly significant decrease in lactate clearance in LPS animals (point B: 46 [30-180] vs. 1212 [743-2116] ml/min, p < 0.01; point D: 113 [65-322] vs. 944 [363-1235] ml/min, p < 0.01). Endotoxemia induces an early and severe impairment in lactate clearance that is not related to total liver hypoperfusion.
    Critical care (London, England) 04/2015; 19(1):188. DOI:10.1186/s13054-015-0928-3
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Breast cancer is one of the major surgical problems encountered in Libya. Lactic acidosis is a universal complication in breast cancer patients and can be considered a possible prognostic marker. Therefore, it will be beneficial to correctly understand and review the biochemistry underlying lactic acidosis and its possible significance as a prognostic marker in critical care patients, including breast cancer.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background:To identify metabolic biomarkers that can be used to differentiate sepsis from systemic inflammatory response syndrome (SIRS), assess severity and predict outcomes. Methods:65 patients were involved in this study including 35 patients with sepsis, 15 patients with SIRS and 15 normal patients. Small metabolites that were present in patient serum samples were measured by liquid chromatography mass spectrometry techniques and analysed using multivariate statistical methods. Results:The metabolic profiling of normal patients and patients with SIRS or sepsis was markedly different. A significant decrease in the levels of lactitol dehydrate andS-phenyl-D-cysteine and an increase in the levels of S-(3-methylbutanoyl)-dihydrolipoamide-E andN-nonanoyl glycine were observed in patients with sepsis in comparison to patients with SIRS ( p<0.05). Patients with severe sepsis and septic shock displayed lower levels of glyceryl-phosphoryl-ethanolamine, Ne,Ne dimethyllysine, phenylacetamide andD-cysteine (p<0.05) in their sera. The profiles of patients with sepsis 48 h before death illustrated an obvious state of metabolic disorder, such thatS-(3-methylbutanoyl)-dihydrolipoamide-E, phosphatidylglycerol (22:2 (13Z,16Z)/0:0), glycerophosphocholine andS-succinyl glutathione were significantly decreased (p<0.05). The receiver operating characteristic curve of the differential expression of these metabolites was also performed. Conclusions:The body produces significant evidence of metabolic disorder during SIRS or sepsis. Seven metabolites may potentially be used to diagnose sepsis.
    05/2014; 1(1). DOI:10.1136/bmjresp-2014-000056